GDNSF logo

Goodness Growth Holdings, Inc. (GDNSF) Aktienanalyse

Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Mit einem Kurs von $ ist Goodness Growth Holdings, Inc. (GDNSF) ein Healthcare-Unternehmen mit einer Bewertung von 0. Die Aktie erzielt 64/100, eine moderate Bewertung basierend auf 9 quantitativen KPIs.

Zuletzt analysiert: 16. März 2026
64/100 KI-Bewertung

Goodness Growth Holdings, Inc. (GDNSF) Gesundheitswesen & Pipeline-Uebersicht

CEOJoshua Nathaniel Rosen
Mitarbeiter385
HauptsitzMinneapolis, US
IPO-Jahr2019

Goodness Growth Holdings, Inc. cultivates and distributes cannabis products through its Green Goods dispensaries and wholesale channels. With a focus on environmentally friendly cultivation and pharmaceutical-grade extracts, the company operates in a rapidly evolving US cannabis market, facing both growth opportunities and regulatory challenges.

Datenherkunft | Finanzdaten Quantitative Analyse NASDAQ Analyse: 16. März 2026

Investmentthese

Goodness Growth Holdings, Inc. presents a speculative investment opportunity within the evolving US cannabis market. The company's focus on physician-led operations and environmentally friendly cultivation could appeal to health-conscious consumers and environmentally focused investors. However, the company's negative P/E ratio of -11.69 and a profit margin of -19.4% indicate financial challenges. Growth catalysts include expansion into new states and increased wholesale distribution. Key risks include regulatory uncertainty, competition from larger cannabis companies, and the need to achieve profitability. The company's beta of 1.42 suggests higher volatility compared to the broader market.

Basierend auf FMP-Finanzdaten und quantitativer Analyse

Wichtige Highlights

  • Operates 18 dispensaries across Maryland, Minnesota, New Mexico, and New York as of March 11, 2022.
  • Gross Margin of 43.8% indicates potential for profitability if operating expenses are managed effectively.
  • Market Cap of $0.06B reflects its small size and potential for high growth or significant risk.
  • Cultivates cannabis in environmentally friendly greenhouses, appealing to environmentally conscious consumers.
  • Sells products through both its own Green Goods dispensaries and third-party wholesale channels, diversifying revenue streams.

Wettbewerber & Vergleichsunternehmen

Staerken

  • Physician-led approach
  • Environmentally friendly cultivation practices
  • Established retail dispensary network
  • Wholesale distribution channels

Schwaechen

  • Negative profit margin
  • Limited geographic presence
  • Small market capitalization
  • Reliance on evolving regulatory landscape

Katalysatoren

  • Upcoming: Potential legalization of cannabis in additional states, expanding market opportunities.
  • Ongoing: Expansion of the Green Goods dispensary network.
  • Ongoing: Development and launch of new cannabis products and formulations.
  • Ongoing: Increasing wholesale distribution agreements with third-party dispensaries.

Risiken

  • Potential: Regulatory changes and uncertainty in the cannabis industry.
  • Ongoing: Competition from larger and more established cannabis companies.
  • Ongoing: Fluctuations in cannabis prices and market demand.
  • Potential: Difficulty in obtaining financing and capital for expansion.
  • Ongoing: Negative profit margin and the need to achieve profitability.

Wachstumschancen

  • Expansion into New States: Legalization of cannabis in additional states presents a significant growth opportunity for Goodness Growth. Entering new markets would allow the company to increase its revenue base and expand its brand presence. The timeline for this growth is dependent on the pace of legalization efforts in various states, but represents a substantial long-term opportunity.
  • Increased Wholesale Distribution: Expanding its wholesale distribution network to third-party dispensaries can significantly increase Goodness Growth's revenue. By partnering with more dispensaries, the company can reach a wider customer base without the capital expenditures associated with opening new retail locations. This strategy can be implemented relatively quickly, providing near-term revenue growth.
  • Development of New Cannabis Products: Investing in research and development to create new and innovative cannabis products can drive growth. This includes developing new strains, formulations, and delivery methods to meet evolving consumer preferences. The timeline for this growth depends on the R&D process, but successful product launches can create a competitive advantage.
  • Focus on Medical Cannabis Market: Goodness Growth's physician-led approach positions it well to capitalize on the medical cannabis market. By focusing on developing cannabis-based therapies for specific medical conditions, the company can attract patients seeking alternative treatments. This market segment is expected to grow as more research supports the therapeutic benefits of cannabis.
  • Strategic Partnerships and Acquisitions: Forming strategic partnerships with other companies in the cannabis industry or acquiring smaller players can accelerate growth. Partnerships can provide access to new markets, technologies, or distribution channels. Acquisitions can consolidate market share and create synergies. These opportunities can arise at any time, depending on market conditions and company strategy.

Chancen

  • Expansion into new states
  • Increased wholesale distribution
  • Development of new cannabis products
  • Focus on medical cannabis market

Risiken

  • Regulatory uncertainty
  • Competition from larger cannabis companies
  • Fluctuations in cannabis prices
  • Changes in consumer preferences

Wettbewerbsvorteile

  • Physician-led approach provides credibility in the medical cannabis market.
  • Environmentally friendly cultivation practices appeal to eco-conscious consumers.
  • Established network of Green Goods dispensaries provides a direct sales channel.
  • Proprietary formulations and extraction processes create product differentiation.

Ueber GDNSF

Goodness Growth Holdings, Inc., formerly known as Vireo Health International Inc., is a physician-led cannabis company established to cultivate, manufacture, and distribute cannabis products in the United States. Founded with a commitment to environmentally sustainable practices, the company operates greenhouses for cannabis cultivation and produces pharmaceutical-grade cannabis extracts. Goodness Growth sells its products through its network of Green Goods retail dispensaries and via wholesale agreements with third-party dispensaries. As of March 11, 2022, the company managed 18 dispensaries across Maryland, Minnesota, New Mexico, and New York. Additionally, the company supplies wholesale cannabis products to third-party companies in Arizona, Maryland, Minnesota, and New York. The company changed its name to Goodness Growth Holdings, Inc. in June 2021, and is headquartered in Minneapolis, Minnesota. The company aims to provide high-quality cannabis products while maintaining environmentally conscious and physician-led operational standards.

Was das Unternehmen tut

  • Cultivates cannabis in environmentally friendly greenhouses.
  • Manufactures pharmaceutical-grade cannabis extracts.
  • Operates a network of Green Goods retail dispensaries.
  • Sells cannabis products through third-party dispensaries.
  • Develops and markets cannabis-based therapies.
  • Engages in wholesale distribution of cannabis products.

Geschaeftsmodell

  • Cultivation and processing of cannabis.
  • Retail sales through company-owned dispensaries.
  • Wholesale distribution to third-party retailers.
  • Development and sale of cannabis extracts and derivative products.

Branchenkontext

Goodness Growth Holdings operates within the rapidly expanding US cannabis market, which is characterized by evolving regulations and increasing consumer acceptance. The industry is highly competitive, with companies like BIOGF (BioHarvest Sciences Inc.), BSTG (BioStar Group, Inc.), EEOIF (Empower Clinics Inc.), EOFBY (EnWave Corporation), and HRPMF (Heritage Cannabis Holdings Corp) vying for market share. The trend towards legalization in more states presents significant growth opportunities, but also regulatory hurdles and compliance costs. Companies that can establish strong brands and efficient operations are best positioned to succeed.

Wichtige Kunden

  • Medical cannabis patients seeking alternative therapies.
  • Adult-use cannabis consumers in legalized states.
  • Third-party dispensaries purchasing wholesale products.
  • Healthcare providers recommending cannabis treatments.
KI-Zuversicht: 71% Aktualisiert: 16. März 2026

Finanzdaten

Chart & Info

Goodness Growth Holdings, Inc. (GDNSF) Aktienkurs: Price data unavailable

Aktuelle Nachrichten

Keine aktuellen Nachrichten fuer GDNSF verfuegbar.

Analystenkonsens

Konsens-Bewertung

Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer GDNSF.

Kursziele

Wall-Street-Kurszielanalyse fuer GDNSF.

MoonshotScore

64/100

Was bedeutet diese Bewertung?

Der MoonshotScore bewertet das Wachstumspotenzial von GDNSF auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.

Fuehrung: Joshua Nathaniel Rosen

CEO

Joshua Nathaniel Rosen serves as the CEO of Goodness Growth Holdings, Inc. His background and specific career history prior to joining Goodness Growth are not detailed in the provided data. As CEO, he is responsible for leading the company's strategic direction, overseeing operations, and driving growth in the competitive cannabis market. His leadership is crucial for navigating the regulatory complexities and capitalizing on the opportunities within the evolving industry.

Erfolgsbilanz: Due to limited information, Joshua Nathaniel Rosen's specific achievements and strategic decisions at Goodness Growth Holdings, Inc. cannot be fully assessed. However, as CEO, he is responsible for guiding the company's expansion, managing its financial performance, and ensuring compliance with regulations. His success will be measured by the company's ability to achieve profitability and increase market share in the long term.

GDNSF OTC-Marktinformationen

The OTC Other tier represents the lowest tier of the OTC market, indicating that Goodness Growth Holdings, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies on this tier may have limited information available to investors, and trading activity can be sporadic. Unlike stocks listed on major exchanges like the NYSE or NASDAQ, OTC Other stocks often have less stringent listing requirements, leading to increased risk for investors.

  • OTC-Stufe: OTC Other
  • Offenlegungsstatus: Unknown
Liquiditaet: As an OTC Other stock, GDNSF likely experiences low trading volume and wide bid-ask spreads. This can make it difficult for investors to buy or sell shares quickly and at desired prices. The limited liquidity increases the risk of price volatility and potential losses, particularly for large trades.
OTC-Risikofaktoren:
  • Limited Financial Disclosure: The unknown disclosure status increases the risk due to lack of transparency.
  • Low Liquidity: The stock may be difficult to buy or sell quickly.
  • Price Volatility: OTC stocks are generally more volatile than exchange-listed stocks.
  • Regulatory Scrutiny: Cannabis companies face evolving and uncertain regulations.
  • Going Concern Risk: Companies on the OTC Other tier may have financial difficulties.
Sorgfaltspruefung-Checkliste:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's compliance with cannabis regulations.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before investing.
  • Check for any legal or regulatory actions against the company.
Legitimitaetssignale:
  • Operation of multiple dispensaries in several states.
  • Focus on environmentally friendly cultivation practices.
  • Physician-led approach to cannabis product development.
  • Wholesale distribution agreements with third-party retailers.

GDNSF Healthcare Aktien-FAQ

What are the key factors to evaluate for GDNSF?

Goodness Growth Holdings, Inc. (GDNSF) currently holds an AI score of 64/100, indicating moderate score. Key strength: Physician-led approach. Primary risk to monitor: Potential: Regulatory changes and uncertainty in the cannabis industry.. This is not financial advice.

How frequently does GDNSF data refresh on this page?

GDNSF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What has driven GDNSF's recent stock price performance?

Recent price movement in Goodness Growth Holdings, Inc. (GDNSF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Physician-led approach. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.

Should investors consider GDNSF overvalued or undervalued right now?

Determining whether Goodness Growth Holdings, Inc. (GDNSF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.

What research should beginners do before buying GDNSF?

Before investing in Goodness Growth Holdings, Inc. (GDNSF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Why might investors consider adding GDNSF to a portfolio?

Potential reasons to consider Goodness Growth Holdings, Inc. (GDNSF) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Physician-led approach. Additionally: Environmentally friendly cultivation practices. The AI-driven MoonshotScore of 64/100 reflects solid quantitative fundamentals. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.

Can I buy fractional shares of GDNSF?

Yes, most major brokerages offer fractional shares of Goodness Growth Holdings, Inc. (GDNSF) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

How can I track GDNSF's earnings and financial reports?

Goodness Growth Holdings, Inc. (GDNSF) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for GDNSF earnings announcements is recommended.

Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.

Offizielle Ressourcen

Analyse aktualisiert am KI-Bewertung taeglich aktualisiert
Datenquellen & Methodik
Marktdaten bereitgestellt von Financial Modeling Prep & Yahoo Finance. KI-Analyse durch proprietaere Algorithmen von Stock Expert AI. Technische Indikatoren nach branchenueblichen Berechnungsstandards. Zuletzt aktualisiert: .

Daten dienen ausschliesslich zu Informationszwecken.

Analysehinweise
  • Limited information available on the company's OTC disclosure status.
  • AI analysis pending, limiting the availability of analyst insights.
Datenquellen

Popular Stocks